These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10891906)

  • 1. Psychological stress and the subsequent appearance of new brain MRI lesions in MS.
    Mohr DC; Goodkin DE; Bacchetti P; Boudewyn AC; Huang L; Marrietta P; Cheuk W; Dee B
    Neurology; 2000 Jul; 55(1):55-61. PubMed ID: 10891906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis.
    Mohr DC; Goodkin DE; Nelson S; Cox D; Weiner M
    Psychosom Med; 2002; 64(5):803-9. PubMed ID: 12271111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis?
    Burns MN; Nawacki E; Kwasny MJ; Pelletier D; Mohr DC
    Psychol Med; 2014 Jan; 44(2):349-59. PubMed ID: 23680407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of war stress on multiple sclerosis exacerbations and radiological disease activity.
    Yamout B; Itani S; Hourany R; Sibaii AM; Yaghi S
    J Neurol Sci; 2010 Jan; 288(1-2):42-4. PubMed ID: 19892371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis.
    Santos AC; Narayanan S; de Stefano N; Tartaglia MC; Francis SJ; Arnaoutelis R; Caramanos Z; Antel JP; Pike GB; Arnold DL
    J Neurol; 2002 Jun; 249(6):662-8. PubMed ID: 12111296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions.
    Smith ME; Stone LA; Albert PS; Frank JA; Martin R; Armstrong M; Maloni H; McFarlin DE; McFarland HF
    Ann Neurol; 1993 May; 33(5):480-9. PubMed ID: 8498825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monthly brain magnetic resonance imaging scans in patients with clinically isolated syndrome.
    Pestalozza IF; Pozzilli C; Di Legge S; Piattella MC; Pantano P; Caramia F; Pasqualetti P; Lenzi GL
    Mult Scler; 2005 Aug; 11(4):390-4. PubMed ID: 16042219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis.
    Khoury SJ; Orav EJ; Guttmann CR; Kikinis R; Jolesz FA; Weiner HL
    Neurology; 1999 Sep; 53(4):758-64. PubMed ID: 10489037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of stress management for the prevention of new brain lesions in MS.
    Mohr DC; Lovera J; Brown T; Cohen B; Neylan T; Henry R; Siddique J; Jin L; Daikh D; Pelletier D
    Neurology; 2012 Jul; 79(5):412-9. PubMed ID: 22786596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective combined brain and spinal cord MRI in clinically isolated syndromes and possible early multiple sclerosis: impact on dissemination in space and time.
    Jacobi C; Hähnel S; Martinez-Torres F; Rieger S; Jüttler E; Heiland S; Jarius S; Meyding-Lamadè U; Storch-Hagenlocher B; Wildemann B
    Eur J Neurol; 2008 Dec; 15(12):1359-64. PubMed ID: 19049554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study.
    Gold J; Marta M; Meier UC; Christensen T; Miller D; Altmann D; Holden D; Bianchi L; Adiutori R; MacManus D; Yousry T; Schmierer K; Turner B; Giovannoni G
    Mult Scler Relat Disord; 2018 Aug; 24():123-128. PubMed ID: 29990894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual.
    Durante L; Zaaraoui W; Rico A; Crespy L; Wybrecht D; Faivre A; Reuter F; Malikova I; Pommier G; Confort-Gouny S; Cozzone PJ; Ranjeva JP; Pelletier J; Boucraut J; Audoin B
    Mult Scler; 2012 May; 18(5):587-91. PubMed ID: 21965422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self reported stressful life events and exacerbations in multiple sclerosis: prospective study.
    Buljevac D; Hop WC; Reedeker W; Janssens AC; van der Meché FG; van Doorn PA; Hintzen RQ
    BMJ; 2003 Sep; 327(7416):646. PubMed ID: 14500435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological time-course of gadolinium-enhancing MRI lesions in patients with multiple sclerosis.
    Giovannoni G; Silver NC; Good CD; Miller DH; Thompson EJ
    Eur Neurol; 2000; 44(4):222-8. PubMed ID: 11096222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis.
    Tortorella C; Bellacosa A; Paolicelli D; Fuiani A; Di Monte E; Simone IL; Giaquinto P; Livrea P; Trojano M
    J Neurol Sci; 2005 Dec; 239(1):95-9. PubMed ID: 16209877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis.
    Bellmann-Strobl J; Wuerfel J; Aktas O; Dörr J; Wernecke KD; Zipp F; Paul F
    Neurology; 2009 Nov; 73(20):1624-7. PubMed ID: 19917984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
    Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
    Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relating multi-sequence longitudinal intensity profiles and clinical covariates in incident multiple sclerosis lesions.
    Sweeney EM; Shinohara RT; Dewey BE; Schindler MK; Muschelli J; Reich DS; Crainiceanu CM; Eloyan A
    Neuroimage Clin; 2016; 10():1-17. PubMed ID: 26693397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis.
    Thorpe JW; Kidd D; Moseley IF; Kenndall BE; Thompson AJ; MacManus DG; McDonald WI; Miller DH
    Neurology; 1996 Feb; 46(2):373-8. PubMed ID: 8614497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.